Research Article

Prognostic Value of Endothelial Progenitor Cells in Acute Myocardial Infarction Patients

Table 2

Comparison of study variables among EPCs (CD34+/CD133+/KDR+ cells) quartiles (M (Q25 and Q75) or M ± SD).

cEPCs Q1 N = 23 (0–0.129%)cEPCs Q2 N = 23 (0.129%–0.170%)cEPCs Q3 N = 23 (0.170%–0.230%)cEPCs Q4 N = 22 (>0.230%)t/F/x2P

Male (n (%))16 (69.6)15 (65.2)21 (91.3)17 (77.3)4.940.18
Age (years)68.3 ± 14.269.7 ± 12.162.3 ± 14.463.0 ± 17.91.460.23
BMI (kg/m2)22.6 ± 2.522.2 ± 2.421.4 ± 1.922.6 ± 2.51.190.32
APACHEⅡscore (points)24.0 ± 8.818.9 ± 7.215.9 ± 4.815.6 ± 5.97.330.000
STEMI (n (%))19 (82.6)15 (65.2)18 (78.3)17 (77.3)2.090.55
cTnI (μg/L)54.4 (38.6, 80.2)75.1 (42.4, 80.2)58.9 (37.0, 76.6)42.8 (32.8, 62.9)5.470.14
NT-proBNP (ng/L)8882.9 (6029.1, 19098.3)13822.9 (8659.3, 18100.7)8949.4 (6823.8, 13822.9)8916.2 (6371.6, 13156.9)4.840.18
VIS (points)16.3 ± 2.914.5 ± 3.415.0 ± 2.915.0 ± 2.61.450.23
GAP (mm Hg)5.9 ± 1.55.7 ± 0.95.5 ± 0.85.0 ± 0.71.690.18
HCY (μmol/L)27.5 (16.4, 49.3)29.1 (20.3, 34.2)17.7 (10.8, 24.3)15.0 (11.3, 30.9)11.760.008
Creatinine (μmol/L)92.2 (74.3, 121.6)84.5 (70.2, 91.0)65.5 (58.7, 88.6)76.5 (59.9, 102.3)8.730.03
C-reactive protein (mg/L)40.5 (10.6, 49.3)21.2 (9.9, 60.0)12.8 (6.9, 30.4)23.4 (9.8, 53.9)6.020.11
HbAlc (%)6.6 ± 1.85.7 ± 1.55.6 ± 1.46.1 ± 1.81.730.17
CI (L/min/m2)2.2 ± 0.72.3 ± 0.62.7 ± 0.72.6 ± 0.63.180.03
Killip classifications (n (%))8.240.04
 Level I–II4 (17.4)10 (43.5)11 (47.8)4 (18.2)
 Level III–IV19 (82.6)13 (56.5)12 (52.2)18 (81.8)
AB (n (%))2.400.02
 Three territories7 (30.4)7 (30.4)3 (13.0)0 (0.0)
 Two territories8 (30.8)2 (8.7)6 (26.1)3 (13.6)
 One territory8 (30.8)14 (60.9)14 (60.9)19 (86.4)

AMI, indicates acute myocardial infarction; BMI, body mass index; STEMI, ST-elevation MI; VIS, vasoactive inotropic score; GAP, central venous-arterial carbon dioxide difference; HCY, homocysteine; CI, cardiac index; AB, atherosclerotic burden.